Insulin therapy improves endothelial insulin resistance in patients with type 2 diabetes and ischemic heart disease

被引：0
|
作者：
Rask-Madsen, C [1 ]
Ihlemann, N [1 ]
Krarup, T [1 ]
Christiansen, E [1 ]
Kober, L [1 ]
Torp-Pedersen, C [1 ]
机构：
[1] Gentofte Univ Hosp, Copenhagen, Denmark
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2001年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：294A / 294A
页数：1
相关论文
共 50 条
  • [1] Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease
    Rask-Madsen, C
    Ihlemann, N
    Krarup, T
    Christiansen, E
    Kober, L
    Kistorp, CN
    Torp-Pedersen, C
    DIABETES, 2001, 50 (11) : 2611 - 2618
  • [2] Endothelial function is insulin resistant in patients with type 2 diabetes and ischemic heart disease
    Rask-Madsen, C
    Ihlemann, N
    Krarup, T
    Christiansen, E
    Kober, L
    Torp-Pedersen, C
    DIABETES, 2000, 49 : A245 - A245
  • [3] Insulin therapy improves endothelial function in type 2 diabetes
    Vehkavaara, S
    Mäkimattila, S
    Schlenzka, A
    Vakkilainen, J
    Westerbacka, J
    Yki-Järvinen, H
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) : 545 - 550
  • [4] IMPACT OF INSULIN THERAPY ON INSULIN RESISTANCE AND A RISK FOR CORONARY HEART DISEASE AND CARDIOVASCULAR DEATH IN PATIENTS WITH TYPE 2 DIABETES
    Ametov, A. S.
    Kochergina, I. I.
    Ulanova, K. A.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (03) : 42 - 46
  • [5] Chromium status and insulin resistance as the risk factors of ischemic heart disease in Type 2 Diabetes Mellitus patients
    Al-Janabi, Ahmed Hashim Abbass
    Abdulzahra, Mohammed Alaa
    Jaafar, Salim Shamkhi
    Hussein, Thaer Shafi
    Al-Mawlah, Yasir Haider
    Journal of Biotech Research, 2023, 15 : 24 - 30
  • [6] 3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes
    Vehkavaara, S
    Yki-Järvinen, H
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (02) : 325 - 330
  • [7] Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin
    Tsai, Ming-Hang
    Chien, Wu-Chien
    Lin, Hsin-Chung
    Chung, Chi-Hsiang
    Chen, Lih-Chyang
    Huang, Kuo-Yang
    Lin, Hsin-An
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (12)
  • [8] INSULIN-RESISTANCE AND ISCHEMIC-HEART-DISEASE IN TYPE-2 DIABETES-MELLITUS
    INCHIOSTRO, S
    BERTOLI, G
    ZANETTE, G
    FRANCESCUTTI, C
    DONADON, V
    DIABETOLOGIA, 1992, 35 : A68 - A68
  • [9] The insulin sensitizer rosiglitazone improves endothelial function in insulin-dependent patients with type 2 diabetes
    Naka, K.
    Papathanassiou, K.
    Kazakos, N.
    Bechlioulis, A.
    Pappas, K.
    Liveris, K.
    Makriyiannis, D.
    Tsatsoulis, A.
    Michalis, L. K.
    EUROPEAN HEART JOURNAL, 2007, 28 : 466 - 466
  • [10] Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin
    Naka, Katerina K.
    Papathanassiou, Katerina
    Bechlioulis, Aris
    Pappas, Konstantinos
    Kazakos, Nikolaos
    Kanioglou, Chryssanthi
    Papafaklis, Michail I.
    Kostoula, Aggeliki
    Vezyraki, Patra
    Makriyiannis, Demetrios
    Tsatsoulis, Agathocles
    Michalis, Lampros K.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (03): : 195 - 201
12345